Spark Neuro (Series A+)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$80,000,000

Company Info
Founding Year
2017
Founders
Spencer Gerrol
Company Description
An applied neuroscience company that collects and quantifies data to create machine-learning based brain health biomarkers for better clinical care and therapeutic discovery. SPARK Neuro is a leading neuroscience company that quantifies brain data for better clinical care and therapeutic discovery. SPARK Neuro's mission is to make brain health assessments a standard part of care. Targeting the 40% of dementia cases that are undiagnosed, SPARK provides a comprehensive assessment service for healthcare payers and providers, propelled by its AI-enabled and FDA-cleared EEG brain scan. SPARK Neuro has a history of collaborating with prestigious institutions like the Mayo Clinic and Johns Hopkins Medicine and has earned funding from the Department of Defense and the National Institutes of Health. SPARK Neuro's flagship innovation delivers an objective, non-invasive, and scalable approach to brain health assessment. SPARK Neuro's mission is to make brain health assessments a standard part of care. Targeting the 40% of dementia cases that are undiagnosed, SPARK provides a comprehensive assessment service for healthcare payers and providers, propelled by its AI-enabled and FDA-cleared EEG brain scan. SPARK Neuro has a history of collaborating with prestigious institutions like the Mayo Clinic and Johns Hopkins Medicine and has earned funding from the Department of Defense and the National Institutes of Health. SPARK Neuro's flagship innovation delivers an objective, non-invasive, and scalable approach to brain health assessment.
Market
Healthcare & Wellness
Coinvestors
Thiel Capital

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement